Thank you, Mr. Chair.
Again, I think this is an answer that will involve both a response from me and a response from my colleague at Health Canada.
At the federal level, we have been working very closely together with key organizations that are involved in research and development, which involves both our National Microbiology Laboratory and other federal players, including another member of the health portfolio beyond Health Canada—the Canadian Institutes of Health Research, CIHR—and some of our colleagues at the National Research Council, to name but a few.
Certainly in the context of different initiatives, there are efforts under way to support researchers in Canada and abroad in the context of the development of a potential vaccine for COVID-19.
This question has come up a couple of times at committee in the past, and I think we all recognize that it will take a number of months before any vaccine may be developed, trialed, proven to be successful, and then potentially produced and rolled out for the general population. I think when Dr. Tam was asked that question, which I think was the first time we were at committee together, she talked about an 18-month window.
Perhaps I will ask my colleague from Health Canada if he would like to add anything.